Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential

被引:45
|
作者
Galletti, Giuseppe [1 ,2 ]
Portella, Luigi [1 ,2 ]
Tagawa, Scott T. [1 ,2 ]
Kirby, Brian J. [1 ,2 ,3 ]
Giannakakou, Paraskevi [1 ,2 ]
Nanus, David M. [1 ,2 ]
机构
[1] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY 10021 USA
[2] Weill Cornell Med Coll, Weill Cornell Canc Ctr, New York, NY 10021 USA
[3] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA
关键词
MITOXANTRONE PLUS PREDNISONE; ANDROGEN RECEPTOR; PERIPHERAL-BLOOD; BREAST-CANCER; ANTITUMOR-ACTIVITY; INCREASED SURVIVAL; PREDICT SURVIVAL; END-POINTS; ANTIGEN; EXPRESSION;
D O I
10.1007/s40291-014-0101-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.
引用
收藏
页码:389 / 402
页数:14
相关论文
共 50 条
  • [1] Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential
    Giuseppe Galletti
    Luigi Portella
    Scott T. Tagawa
    Brian J. Kirby
    Paraskevi Giannakakou
    David M. Nanus
    Molecular Diagnosis & Therapy, 2014, 18 : 389 - 402
  • [2] Circulating Melanoma Cells in the Diagnosis and Monitoring of Melanoma: An Appraisal of Clinical Potential
    Brigid S. Mumford
    Gavin P. Robertson
    Molecular Diagnosis & Therapy, 2014, 18 : 175 - 183
  • [3] Circulating Melanoma Cells in the Diagnosis and Monitoring of Melanoma: An Appraisal of Clinical Potential
    Mumford, Brigid S.
    Robertson, Gavin P.
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (02) : 175 - 183
  • [4] A Systematic Review of Circulating Tumor Cells Clinical Application in Prostate Cancer Diagnosis
    Enikeev, Dmitry
    Morozov, Andrey
    Babaevskaya, Diana
    Bazarkin, Andrey
    Malavaud, Bernard
    CANCERS, 2022, 14 (15)
  • [5] The Clinical Application and Potential Roles of Circulating Tumor Cells in Bladder Cancer and Prostate Cancer
    Yan, Hang
    Dittmar, Florian
    Schagdarsurengin, Undraga
    Wagenlehner, Florian
    UROLOGY, 2020, 145 : 30 - 37
  • [6] Circulating tumor cells in the clinical cancer diagnosis
    Zhang, P.
    Zhou, H.
    Lu, K.
    Wang, Y.
    Feng, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 279 - 282
  • [7] Circulating tumor cells in the clinical cancer diagnosis
    P. Zhang
    H. Zhou
    K. Lu
    Y. Wang
    T. Feng
    Clinical and Translational Oncology, 2020, 22 : 279 - 282
  • [8] Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
    Alemzadeh, Effat
    Allahqoli, Leila
    Dehghan, Hamideh
    Mazidimoradi, Afrooz
    Ghasempour, Alireza
    Salehiniya, Hamid
    ONCOLOGY RESEARCH, 2023, 31 (05) : 667 - 675
  • [9] Research Progress for the Clinical Application of Circulating Tumor Cells in Prostate Cancer Diagnosis and Treatment
    Yang, Mei
    Zhang, Xiaotian
    Guo, Lixia
    Liu, Xiumin
    Wu, Jing
    Zhu, Hongquan
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [10] Circulating Extracellular Vesicles in Cancer Diagnosis and MonitoringAn Appraisal of Clinical Potential
    Dong-Sic Choi
    Jaewook Lee
    Gyeongyun Go
    Yoon-Keun Kim
    Yong Song Gho
    Molecular Diagnosis & Therapy, 2013, 17 : 265 - 271